Literature DB >> 16483416

A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa.

Benjamin Jeffs1.   

Abstract

The viral haemorrhagic fevers are a group of diseases that share many clinical features. Ebola, Marburg and Lassa are diseases that cause a relatively small number of deaths globally, but pose special risks to medical staff due to the ease of transmission, and can have a profound impact to the communities they affect. This article gives a brief overview of diseases caused by the Ebola, Marburg and Lassa viruses. It gives some practical advice to the clinician on the diagnosis and management of these diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16483416     DOI: 10.1258/004947506775598914

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  19 in total

1.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

Review 2.  Viral Hemorrhagic Fever Diagnostics.

Authors:  Lori D Racsa; Colleen S Kraft; Gene G Olinger; Lisa E Hensley
Journal:  Clin Infect Dis       Date:  2015-09-09       Impact factor: 9.079

Review 3.  Current ebola vaccines.

Authors:  Thomas Hoenen; Allison Groseth; Heinz Feldmann
Journal:  Expert Opin Biol Ther       Date:  2012-05-05       Impact factor: 4.388

Review 4.  Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes.

Authors:  Lisa M Bebell; Titilope Oduyebo; Laura E Riley
Journal:  Birth Defects Res       Date:  2017-03-15       Impact factor: 2.344

5.  Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.

Authors:  Luis M Branco; Jessica N Grove; Lina M Moses; Augustine Goba; Mohammed Fullah; Mambu Momoh; Randal J Schoepp; Daniel G Bausch; Robert F Garry
Journal:  Virol J       Date:  2010-11-09       Impact factor: 4.099

6.  Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.

Authors:  Masayuki Saijo; Marie-Claude Georges-Courbot; Philippe Marianneau; Victor Romanowski; Shuetsu Fukushi; Tetsuya Mizutani; Alain-Jean Georges; Takeshi Kurata; Ichiro Kurane; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

7.  Infection control during filoviral hemorrhagic Fever outbreaks.

Authors:  Vanessa N Raabea; Matthias Borcherta
Journal:  J Glob Infect Dis       Date:  2012-01

Review 8.  Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers.

Authors:  Shuetsu Fukushi; Hideki Tani; Tomoki Yoshikawa; Masayuki Saijo; Shigeru Morikawa
Journal:  Viruses       Date:  2012-10-12       Impact factor: 5.048

9.  Association of clinical signs and symptoms of Ebola viral disease with case fatality: a systematic review and meta-analysis.

Authors:  Harsha Moole; Swetha Chitta; Darlyn Victor; Manasa Kandula; Vishnu Moole; Harshavardhan Ghadiam; Anusha Akepati; Charan Yerasi; Achuta Uppu; Sowmya Dharmapuri; Raghuveer Boddireddy; Jacqueline Fischer; Teresa Lynch
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-09-01

10.  Ebola outbreak response; experience and development of screening tools for viral haemorrhagic fever (VHF) in a HIV center of excellence near to VHF epicentres.

Authors:  Rosalind Parkes-Ratanshi; Ali Elbireer; Betty Mbambu; Faridah Mayanja; Alex Coutinho; Concepta Merry
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.